Phospho-MYC (T358) Antibody

What is Phospho-MYC (T358) and why is it important in research?

Phospho-MYC (T358) refers to the MYC protein when phosphorylated at threonine 358. MYC is a transcription factor that binds DNA and activates growth-related genes. It plays critical roles in cell proliferation, metabolism, and oncogenesis. Phosphorylation at specific sites, including T358/T58, regulates MYC's stability, activity, and proteasomal degradation.

The phosphorylation state of MYC provides crucial insights into its functional status, as phosphorylation at T358/T58 works in conjunction with phosphorylation at S62 to control the protein's degradation through the ubiquitin-proteasome pathway. Understanding this phosphorylation is particularly important because abnormal MYC activity is associated with numerous cancers .

What are the main applications of Phospho-MYC (T358) antibodies?

Phospho-MYC (T358) antibodies are versatile tools employed in multiple experimental approaches:

These applications enable researchers to examine MYC phosphorylation status across different experimental contexts, from protein extracts to intact cells and tissues .

How do I distinguish between phosphorylated and non-phosphorylated MYC in my experiments?

To effectively distinguish phosphorylated from non-phosphorylated MYC:

• Use antibody pairs: Employ both phospho-specific (recognizing only T358 phosphorylated MYC) and total MYC antibodies (recognizing MYC regardless of phosphorylation status) in parallel samples .

• Include phosphatase treatment controls: Treat a portion of your sample with lambda phosphatase to remove phosphate groups, which should eliminate signal from phospho-specific antibodies .

• Use phosphorylation inducers: Compare samples treated with phosphatase inhibitors (like Calyculin A or Okadaic Acid) to enhance phosphorylation signals against untreated controls .

The observed molecular weight of phosphorylated MYC is typically 57-62 kDa, which may differ slightly from the calculated weight of 48-49 kDa due to post-translational modifications .

What are the optimal storage conditions for Phospho-MYC (T358) antibodies?

Proper storage is crucial for maintaining antibody activity:

• Storage temperature: Store at -20°C or lower

• Avoid repeated freeze-thaw cycles by making appropriate aliquots

• Return antibodies to -20°C immediately after use

• Some formulations contain 50% glycerol, 0.02% sodium azide in PBS (pH 7.3-7.4)

• For long-term storage (up to 1 year), maintain at -20°C without aliquoting (when specified by manufacturer)

Following these guidelines ensures antibody stability and consistent experimental results over time.

What sample preparation techniques yield optimal results with Phospho-MYC (T358) antibodies?

Effective sample preparation is essential for reliable phospho-protein detection:

• Cell lysis: Use buffers containing phosphatase inhibitors (such as sodium fluoride, sodium orthovanadate, and β-glycerophosphate) to preserve phosphorylation status

• Protein extraction: Perform on ice and process samples quickly to minimize phosphatase activity

• For Western blotting: Use 5% non-fat dry milk in TBST as a blocking solution

• For immunofluorescence: Fix cells with 4% paraformaldehyde and permeabilize with 0.1% Triton X-100

• For proximity ligation assays: Follow manufacturer protocols for dual antibody application (typically 1:1200 for rabbit polyclonal phospho-specific antibody and 1:50 for mouse monoclonal total MYC antibody)

These preparation techniques help maintain phosphorylation status and reduce background signal.

How should working dilutions be determined for different applications?

Optimization of antibody dilutions is application-dependent:

Always include appropriate controls when determining optimal dilutions, including positive controls (samples known to express phosphorylated MYC) and negative controls (phosphatase-treated samples) .

What controls should be included when using Phospho-MYC (T358) antibodies?

Robust experimental design requires appropriate controls:

Essential Controls:

• Positive control: Cell lines known to express phosphorylated MYC (e.g., HeLa cells treated with phosphatase inhibitors)

• Negative control: Samples treated with lambda phosphatase to remove phosphorylation

• Loading control: To ensure equal protein loading (e.g., actin, GAPDH)

• Antibody specificity control: Peptide competition assay using the immunizing phosphopeptide

Advanced Controls:

• Genetic controls: MYC-knockout or MYC-T358A mutant cells (where threonine is replaced with alanine to prevent phosphorylation)

• Kinase/phosphatase manipulation: Treatment with specific kinase inhibitors or phosphatase activators that affect MYC phosphorylation

These controls help validate findings and ensure experimental rigor .

How can I validate the specificity of Phospho-MYC (T358) antibodies?

Antibody validation is critical for reliable results:

• Phosphatase treatment: Signal should diminish or disappear after treatment with lambda phosphatase

• Phosphorylation induction: Enhanced signal should be observed after treatment with phosphatase inhibitors like Calyculin A (200nM) and Okadaic Acid (1μM)

• Peptide competition: Pre-incubation of the antibody with the phosphorylated peptide immunogen should block specific binding

• Western blot profile: The antibody should detect a band at the expected molecular weight (~57-62kDa for phosphorylated MYC)

• Cross-validation: Compare results with alternative phospho-specific antibodies targeting the same site

These validation approaches ensure that the detected signal genuinely represents phosphorylated MYC protein.

What are common troubleshooting approaches for experiments using Phospho-MYC (T358) antibodies?

When encountering experimental issues:

Each experimental system may require specific optimization strategies to achieve consistent and reliable results .

How can Proximity Ligation Assay (PLA) be used to study MYC phosphorylation in situ?

PLA offers unique advantages for studying phosphorylated proteins in their cellular context:

The technique involves:

• Using two antibodies: One targeting the phosphorylated site (rabbit polyclonal anti-phospho-MYC T358) and another recognizing total MYC protein (mouse monoclonal anti-MYC)

• Secondary antibodies conjugated with oligonucleotides allow signal amplification when the two primary antibodies bind in close proximity

• Each resulting fluorescent dot represents a single phosphorylated MYC protein

For optimal results:

• Use the recommended dilutions (typically 1:1200 for rabbit polyclonal and 1:50 for mouse monoclonal antibodies)

• Analyze images with appropriate software (e.g., BlobFinder from Uppsala University)

• Include appropriate controls (phosphatase-treated samples as negative controls)

This technique provides spatial information about MYC phosphorylation that cannot be obtained through biochemical methods alone.

What methods can be used to study the dynamics of MYC T358 phosphorylation in relation to cellular processes?

To investigate dynamic phosphorylation events:

• Time-course experiments:

  • Treat cells with relevant stimuli (growth factors, stress inducers)

  • Collect samples at multiple time points

  • Analyze using Western blotting with phospho-specific and total MYC antibodies

• Pharmacological manipulation:

  • Use kinase inhibitors (for GSK-3β, which phosphorylates MYC)

  • Apply phosphatase inhibitors (Calyculin A, Okadaic Acid)

  • Compare phosphorylation profiles before and after treatment

• Cell cycle synchronization:

  • Synchronize cells at different cell cycle phases

  • Analyze MYC phosphorylation status across the cell cycle

  • Correlate with other cell cycle markers

• Live-cell imaging approaches:

  • Express fluorescently-tagged MYC constructs

  • Use FRET-based biosensors to monitor phosphorylation events in real-time

  • Combine with phospho-specific antibody staining in fixed time points

These approaches provide insights into how MYC phosphorylation is regulated in different cellular contexts .

How does phosphorylation at T358/T58 interact with other post-translational modifications of MYC?

MYC undergoes multiple post-translational modifications that interact in complex ways:

• Hierarchical phosphorylation: Phosphorylation at Ser62 serves as a priming site for subsequent phosphorylation at Thr58/T358 by GSK-3

• Phosphorylation-dependent ubiquitination: T58/T358 phosphorylation, together with S62 phosphorylation, is required for ubiquitination by the SCF(FBXW7) complex, leading to proteasomal degradation

• Regulatory phosphatases: Protein phosphatase 2A (PPP2CA) can dephosphorylate Ser62, promoting MYC degradation, and this interaction is enhanced by AMBRA1

• Deubiquitinating enzymes: USP28 counteracts ubiquitination in the nucleoplasm by interacting with FBXW7α, while USP36 performs this function in the nucleolus

Understanding these complex interactions is crucial for interpreting experimental results and designing interventions targeting MYC stability and function .

How should quantitative analysis of Phospho-MYC (T358) levels be performed?

For rigorous quantitative analysis:

• Western blot quantification:

  • Always normalize phospho-MYC signal to total MYC levels

  • Use a linear range of detection (avoid saturated signals)

  • Apply appropriate software (ImageJ, Li-COR Image Studio, etc.)

  • Present data as phospho-MYC/total MYC ratio

• Immunofluorescence quantification:

  • For PLA: Count dots per cell using appropriate software (e.g., BlobFinder)

  • For standard IF: Measure mean fluorescence intensity in relevant cellular compartments

  • Analyze sufficient cell numbers for statistical validity (typically >100 cells per condition)

• Statistical considerations:

  • Perform experiments in at least three biological replicates

  • Apply appropriate statistical tests based on data distribution

  • Report both fold changes and absolute values when relevant

These approaches enable reliable comparison of phosphorylation levels across experimental conditions .

How do I interpret discrepancies between results obtained with different phospho-MYC detection methods?

When facing inconsistent results:

What are the emerging technologies for studying MYC phosphorylation beyond traditional antibody-based methods?

Cutting-edge approaches include:

• Mass spectrometry-based phosphoproteomics:

  • Allows unbiased detection of multiple phosphorylation sites

  • Can identify novel sites and quantify stoichiometry

  • Enables comprehensive mapping of phosphorylation networks

• CRISPR-based genetic models:

  • Generation of phospho-mutant MYC variants (T358A/T58A)

  • Creation of endogenously tagged MYC for live imaging

  • Development of degradation-resistant MYC mutants

• Biosensors and live-cell technologies:

  • FRET-based sensors for real-time phosphorylation monitoring

  • Optogenetic tools to spatiotemporally control kinase activity

  • Single-molecule tracking of MYC phosphorylation states

• Computational modeling:

  • Integration of phosphorylation data with other PTMs

  • Prediction of phosphorylation effects on protein structure and interactions

  • Simulation of phosphorylation dynamics in complex cellular networks

These emerging approaches complement antibody-based detection methods and provide deeper insights into MYC phosphorylation biology.